Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).

Results

Naziv:	Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).
Autori:	Glimelius, Bengt; Manojlović, Nebojša S. ; Pfeiffer, Per; Mosidze, Baadur; Petrova-Kurteva, Galina; Karlberg, Mia; Mahalingam, Devalingam; Bengtson, Marie; Nasstrom, Jacques
Godina:	2016
Publikacija:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X e1527-7755 Journal of Clinical Oncology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 34 br. 15 Suppl. S (Meeting Abstract 10018)
DOI:	10.1200/JCO.2016.34.15_suppl.10018
WoS-ID:	000404712500007
URI:	https://enauka.gov.rs/handle/123456789/815202
URL:	https://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.10018
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

2
OpenCitations

1
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM